Drug
Tas 102
Tas 102: highest development phase Phase 1, developed by Natera. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Natera
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAS-102 NCT04920032 | Phase 1 | Colon Adenocarcinoma |
Latest
No recent events.
Follow Tas 102 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.